Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Non-Pharmacologic Treatment of Rosacea | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Non-Pedicle Supplemental Fixation Device for Use in the Non-Cervical Spine | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Non-Invasive Measurement of Left Ventricular End Diastolic Pressure (LVEDP) in the Outpatient Setting | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Non-Contact Ultrasound Treatment for Wounds | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Nitisinone | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Niktimvo (axatilimab-csfr) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Next-Generation Sequencing for the Assessment of Measurable Residual Disease | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | New Drug Approvals and Newly Approved Indications for Currently Available Medications | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Neuromuscular Electrical Stimulation (NMES) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Neurofeedback | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Neural Therapy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Nerve Graft With Radical Prostatectomy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Nerve Fiber Density Measurement | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Neonatal Fc Receptor Blockers | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Negative Pressure Wound Therapy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Needle-Free Insulin Injection Systems | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Navigated Transcranial Magnetic Stimulation | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Natroba (spinosad) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Myoelectric Prosthetic and Orthotic Components for the Upper Limb | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Myocardial Sympathetic Innervation Imaging in Individuals with Heart Failure | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Myocardial Strain Imaging | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Myeloperoxidase (MPO) Immunoassay for Cardiac Disease Risk | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Multitarget Polymerase Chain Reaction Testing for Diagnosis of Bacterial Vaginosis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Multispectral Digital Skin Lesion Analysis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Multiple Sclerosis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Multimarker Serum Testing Related to Ovarian Cancer | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Multicancer Early Detection Testing | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Multibiomarker Disease Activity Blood Test for Rheumatoid Arthritis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Multianalyte Assays with Algorithmic Analyses for Predicting Risk of Type 2 Diabetes | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Motorized Wheelchairs | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Morbid Obesity | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Monoclonal Antibody Therapies for Migraine Prevention | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Monoclonal Antibodies for Treatment of Alzheimer’s Disease | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Monitored Anesthesia Care during Gastrointestinal Endoscopy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Molecular Testing in the Management of Pulmonary Nodules | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Molecular Testing for the Management of Pancreatic Cysts and Solid Pancreaticobiliary Lesions | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Molecular Testing for Germline Variants Associated with Ovarian Cancer (BRIP1, RAD51C, RAD51D, NBN) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Molecular Markers in Fine Needle Aspirates of the Thyroid | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Molecular Genomic Profiling for Cancers of Unknown Primary | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Miudella (copper intrauterine device) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Miscellaneous Genetic and Molecular Diagnostic Tests | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Miscellaneous (Noncardiac, Nononcologic) Applications of Fluorine 18 Fluorodeoxyglucose Positron Emission Tomography | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Minimally Invasive Approaches to Vertebral Fractures and Osteolytic Lesions of the Spine | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Minimally Invasive Ablation Procedures for Morton and Other Peripheral Neuromas | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Microwave Tumor Ablation | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Microprocessor-Controlled Prostheses for the Lower Limb | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Microarray-Based Gene Expression Profile Testing for Multiple Myeloma Risk Stratification | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Metformin Extended-Release Formulations | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Meniscal Allografts and Other Meniscal Implants | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Melanoma Vaccines | New policy |